Eco R1 Capital, LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $1.27 Billion distributed in 46 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Apellis Pharmaceuticals, Inc. with a value of $260M, Jazz Pharmaceuticals PLC with a value of $212M, Crinetics Pharmaceuticals, Inc. with a value of $144M, Prothena Corp Public LTD CO with a value of $143M, and Sarepta Therapeutics, Inc. with a value of $82.5M.
Examining the 13F form we can see an decrease of $868M in the current position value, from $2.14B to 1.27B.
Eco R1 Capital, LLC is based out at San Francisco, CA
Below you can find more details about Eco R1 Capital, LLC portfolio as well as his latest detailed transactions.
